Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae

Su Mon Aye,Irene Galani,Heidi Yu,Jiping Wang,Ke Chen,Hasini Wickremasinghe,Ilias Karaiskos,Jinxin Zhao,Tony Velkov,Helen Giamarellou,Yu-Wei Lin,Jian Li,Phillip J. Bergen,Brian T. Tsuji

DOI: https://doi.org/10.1128/aac.00246-20

IF: 5.938

2020-07-22

Antimicrobial Agents and Chemotherapy

Abstract:Resistance to polymyxin antibiotics is increasing. Without new antibiotic classes, combination therapy is often required. We systematically investigated bacterial killing with polymyxin-based combinations against multidrug-resistant (including polymyxin-resistant), carbapenemase-producing Klebsiella pneumoniae . Monotherapies and double- and triple-combination therapies were compared to identify the most efficacious treatment using static time-kill studies (24 h, six isolates), an in vitro pharmacokinetic/pharmacodynamic model (IVM; 48 h, two isolates), and the mouse thigh infection model (24 h, six isolates).

pharmacology & pharmacy,microbiology